Bachem Holding AG is a leading pharmaceutical company based in Switzerland with a low-risk ESG score of 19.2. Specializing in peptides and oligonucleotides, Bachem offers top-notch services to the pharmaceutical and biotechnology sectors. Known for its high-quality products under the Bachem and Clinalfa brands, the company operates in Europe/Asia and North America. Services offered include CMC development, commercial API, research and specialties, and various other capabilities.